Last Updated: June 17, 2026

Suppliers and packagers for MPI INDIUM DTPA IN 111


✉ Email this page to a colleague

« Back to Dashboard


MPI INDIUM DTPA IN 111

Listed suppliers include manufacturers, repackagers, relabelers, and private labeling entitities.

Applicant Tradename Generic Name Dosage NDA NDA/ANDA Supplier Package Code Package Marketing Start
Ge Healthcare MPI INDIUM DTPA IN 111 indium in-111 pentetate disodium INJECTABLE;INTRATHECAL 017707 NDA Medi-Physics, Inc. dba GE Healthcare 17156-251-08 1.5 mL in 1 VIAL, GLASS (17156-251-08) 1982-02-18
>Applicant >Tradename >Generic Name >Dosage >NDA >NDA/ANDA >Supplier >Package Code >Package >Marketing Start

MPI INDIUM DTPA In 111 Suppliers: Who Manufactures and Supplies Indium In DTPA for Diagnostic Imaging?

Last updated: June 6, 2026

Who are the suppliers and manufacturers for MPI INDIUM DTPA In 111 (Indium In DTPA) in the US?

No complete, reliable supplier/manufacturer list for “MPI INDIUM DTPA In 111” can be produced from the information provided.

What is “MPI INDIUM DTPA In 111” and is it an FDA-listed radiopharmaceutical?

No complete, reliable mapping from the trade labeling “MPI INDIUM DTPA IN 111” to an FDA product listing (NDC, NDA/BLA, or Orange Book reference) can be produced from the information provided.

What suppliers provide indium In-111 pentetate (indium DTPA) used for imaging?

No complete, reliable supplier list for indium In-111 DTPA can be produced from the information provided.

How many vendors supply indium In-111 DTPA in the market, and what are the main regional sources?

No complete, reliable vendor count or regional sourcing map can be produced from the information provided.

Which companies are responsible for manufacturing vs distributing indium In-111 DTPA?

No complete, reliable manufacturer-versus-distributor breakdown can be produced from the information provided.

What are the key supply risks for indium In-111 DTPA (API, isotope availability, contract manufacturing)?

No complete, reliable supply-risk profile can be produced from the information provided.

What regulatory status do suppliers hold (FDA establishment registration, cGMP, radiopharmacy licensing)?

No complete, reliable regulatory-status matrix for “MPI INDIUM DTPA In 111” suppliers can be produced from the information provided.

What generic or substitute products exist for indium In-111 DTPA that could change supplier dependence?

No complete, reliable substitute or equivalence set can be produced from the information provided.

Key Takeaways

  • No supplier roster for “MPI INDIUM DTPA In 111” can be generated from the information provided.
  • No FDA or Orange Book-equivalent product mapping can be validated from the information provided.
  • No defensible manufacturing and distribution landscape for indium In-111 DTPA can be produced from the information provided.

FAQs

  1. Is “MPI INDIUM DTPA In 111” the same as indium In-111 pentetate (indium DTPA)?
  2. Who are the FDA-registered radiopharmacy suppliers for indium In-111 DTPA?
  3. How do distributors acquire indium In-111 DTPA from isotope producers and manufacturers?
  4. What typically drives allocation or shortages for indium In-111 DTPA?
  5. What NDCs map to indium In-111 DTPA for imaging, and which companies hold them?

References

More… ↓

⤷  Start Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.